The medical program of CLL is very heterogeneous, starting from a fairly asymptomatic disease which could even regress spontaneously to some progressive sickness that ultimately causes the patient’s Demise, so there has usually been remarkable interest in analyzing the prognosis of individual people. Though lots of prognostic markers are identifi